SCVC

SCVC focuses on investing in cutting-edge technological innovations ranging from biotechnology to quantum computing, seeking partnerships with ventures that share their commitment to enhancing human health and environmental sustainability. Comprised of technology specialists and experienced entrepreneurs, the team gravitates toward visionary founders with ambitious goals to create meaningful global impact. Their investment philosophy centers on supporting scientifically-driven startups that demonstrate potential for transformative breakthroughs in deep tech sectors.

As the dedicated venture capital division of Science Creates, SCVC offers portfolio companies advantages beyond mere financial backing. Their strategic position within the Science Creates ecosystem provides founders with access to specialized incubation facilities, strategic partnerships, and tailored development programs specifically designed for deep technology ventures. This integrated approach creates a supportive environment where scientific innovation can effectively transition from laboratory concepts to commercially viable enterprises.

The investment team brings firsthand entrepreneurial experience to their venture decisions, having previously navigated the challenges of building deep tech companies themselves. This perspective informs their hands-on investment style, where they work closely with portfolio companies to overcome the unique obstacles associated with commercializing complex scientific innovations. Their technical expertise spans multiple disciplines, allowing them to evaluate opportunities across diverse fields including advanced materials, life sciences, quantum technologies, and other frontier sectors.

SCVC distinguishes itself through its commitment to building the venture capital firm they wished existed during their own entrepreneurial journeys. This founder-centric philosophy shapes their approach to patient capital deployment, understanding that deep technology ventures often require longer development timelines than conventional startups. By combining scientific rigor with commercial acumen, they aim to support companies through the critical stages of technology validation, market entry, and scale-up, creating a partnership model that addresses the specific needs of science-based enterprises.